CYTEK BIOSCIENCES INC. - COMMON STOCK
3.7450
01-May-25 09:56:31
15 minutes delayed
Stocks
+0.0350
+0.94%
Today's range
3.6150 - 3.8700
ISIN
N/A
Source
NASDAQ
-
Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
07 Feb 2023 15:05:00 By Nasdaq GlobeNewswire
-
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
07 Feb 2023 08:00:02 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Participate in Upcoming Investor Conferences
06 Feb 2023 15:05:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference
21 Nov 2022 15:05:00 By Nasdaq GlobeNewswire
-
Cytek® Biosciences Introduces Cytek Cloud
15 Nov 2022 09:00:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences Reports Third Quarter 2022 Financial Results
09 Nov 2022 15:05:01 By Nasdaq GlobeNewswire
-
Cytek® Biosciences Names Chris Williams Chief Operating Officer
31 Oct 2022 15:30:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
26 Oct 2022 15:05:00 By Nasdaq GlobeNewswire
-
Cytek to Participate in the 20th Annual Morgan Stanley Global Healthcare Conference
30 Aug 2022 15:05:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences Reports Second Quarter 2022 Financial Results
10 Aug 2022 15:05:01 By Nasdaq GlobeNewswire
-
Cytek to Participate in the 42nd Annual Canaccord Genuity Global Growth Conference
21 Jul 2022 07:00:01 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Report Second Quarter 2022 Financial Results on August 10, 2022
20 Jul 2022 15:05:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Host Inaugural Analyst and Investor Day
01 Jun 2022 15:05:00 By Nasdaq GlobeNewswire
-
Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK Kit
24 May 2022 09:00:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences Reports First Quarter 2022 Financial Results
11 May 2022 15:05:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Report First Quarter Financial Results on May 11, 2022
28 Apr 2022 15:05:02 By Nasdaq GlobeNewswire
-
Cytek Biosciences Appoints Todd Garland Chief Commercial Officer
28 Apr 2022 07:00:04 By Nasdaq GlobeNewswire
-
Cytek Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results
23 Feb 2022 15:05:01 By Nasdaq GlobeNewswire
-
Cytek to Participate in the 42nd Annual Cowen Health Care Conference
16 Feb 2022 15:05:00 By Nasdaq GlobeNewswire
-
Cytek Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
11 Feb 2022 07:00:00 By Nasdaq GlobeNewswire